GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,215,000 | -4.9% | 31,795 | +0.0% | 0.90% | +8.5% |
| Q3 2018 | $1,277,000 | -6.9% | 31,780 | -6.6% | 0.83% | -6.6% |
| Q2 2018 | $1,371,000 | +9.0% | 34,015 | +5.7% | 0.89% | +7.2% |
| Q1 2018 | $1,258,000 | +31.0% | 32,187 | +18.9% | 0.83% | +39.5% |
| Q4 2017 | $960,000 | -14.0% | 27,074 | -0.8% | 0.60% | -23.0% |
| Q3 2017 | $1,116,000 | -34.7% | 27,305 | -31.2% | 0.78% | -41.1% |
| Q2 2017 | $1,710,000 | -4.7% | 39,659 | -6.8% | 1.32% | +11.7% |
| Q1 2017 | $1,794,000 | +0.6% | 42,555 | -8.1% | 1.18% | -1.8% |
| Q4 2016 | $1,784,000 | -31.8% | 46,321 | -23.6% | 1.20% | -34.3% |
| Q3 2016 | $2,616,000 | -16.8% | 60,658 | -16.4% | 1.82% | -21.4% |
| Q2 2016 | $3,144,000 | +7.0% | 72,541 | +0.1% | 2.32% | +5.0% |
| Q1 2016 | $2,939,000 | +17.6% | 72,487 | +17.0% | 2.21% | +18.7% |
| Q4 2015 | $2,500,000 | – | 61,964 | – | 1.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |